<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03863977</url>
  </required_header>
  <id_info>
    <org_study_id>IRB:17100670</org_study_id>
    <nct_id>NCT03863977</nct_id>
  </id_info>
  <brief_title>Post-operative Analgesic Effects of Dexamethasone Added to Bupivacaine in Transversusabdominis Plane (TAP) Block</brief_title>
  <official_title>Comparison of Post-operative Analgesic Effects of Two Doses of Dexamethasone Added to Bupivacaine in Ultrasound-guided Transversusabdominis Plane (TAP) Block for Inguinal Hernia Repair</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
    <is_us_export>No</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      To compare the postoperative analgesic effect of two doses of dexamethasone added to
      bupivacaine in ultrasound-guided TAP block for inguinal hernia repair.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The transverses abdominis plane block (TAP block) is a regional anesthesia technique that
      provides analgesia following abdominal surgery . The TAP block significantly reduces pain
      after open inguinal hernia repair, regardless of whether it is used as a primary anesthesia
      technique or as a complement to general anesthesia, spinal or local anesthesia .

      The investigators designed this study to compare the postoperative analgesic effect of two
      doses of dexamethasone( 4 mg and 8 mg ) added to bupivacaine in ultrasound-guided TAP block
      for inguinal hernia repair.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">March 15, 2019</start_date>
  <completion_date type="Actual">January 1, 2020</completion_date>
  <primary_completion_date type="Actual">December 1, 2019</primary_completion_date>
  <phase>Phase 2/Phase 3</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>60 patients will be divided into two groups according to the dose of dexamethasone added to bupivacaine in the TAP block, I - group ( Group D4 ) 4mg of dexamethasone will be added II - group ( Group D8 ) 8mg of dexamethasone will be added. III-group(control) bupivacaine alone</intervention_model_description>
    <primary_purpose>Prevention</primary_purpose>
    <masking>Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)</masking>
    <masking_description>A blinded physician prepared the study medications in color coded syringes.</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>time of the first analgesic request</measure>
    <time_frame>in the first postoperative 24 hours</time_frame>
    <description>time of the first analgesic request in the first postoperative 24 hours ,patients will receive analgesia if visual analog scale (VAS) score more than 3</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>change in visual analog scale (VAS)</measure>
    <time_frame>2nd, 4th, 8th, 16th, and 24th postoperative hours.</time_frame>
    <description>measuring the change in visual analog scale VAS (0: no pain to 10: worst imaginable pain), to evaluate postoperative analgesia</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">90</enrollment>
  <condition>Postoperative Analgesia</condition>
  <arm_group>
    <arm_group_label>Dex4 group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After the surgery, the patients in this group will receive 4 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Dex8 group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After the surgery, the patients in this group will receive 8 mg dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>control group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>After the surgery, the patients in this group will 1mg/kg of 0.5% bupivacaine in the TAP block.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Dexamethasone</intervention_name>
    <description>After the surgery, dexamethasone added to 1mg/kg of 0.5% bupivacaine in the TAP block.</description>
    <arm_group_label>Dex4 group</arm_group_label>
    <arm_group_label>Dex8 group</arm_group_label>
    <other_name>dexamethasone acetate</other_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine</intervention_name>
    <description>After the surgery,1mg/kg of 0.5% bupivacaine in the TAP block.</description>
    <arm_group_label>Dex4 group</arm_group_label>
    <arm_group_label>Dex8 group</arm_group_label>
    <arm_group_label>control group</arm_group_label>
    <other_name>plain marcaine</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients' age from 18 to 60 years old,

          -  physical status ASA I-II (by the American Society of Anesthesiologists),

          -  Elective unilateral open inguinal hernia repair,

          -  Under spinal anesthesia

        Exclusion Criteria:

          -  age &lt; 18 or &gt; 60,

          -  American society of anesthesiologist (ASA)class III-IV,

          -  known allergy to amino amide local anesthetics,

          -  skin infection and diseases at site of injection.

          -  coagulation disorders,

          -  patients with body mass index (BMI) &gt; 35 kg/m2,

          -  scrotal hernias,
      </textblock>
    </criteria>
    <gender>Male</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Amany Hassan, Lectural</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assiut university, Egypt</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Assiut university hospitals</name>
      <address>
        <city>Assiut</city>
        <state>Assiut Governorate</state>
        <zip>Egypt, 715715</zip>
        <country>Egypt</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>April 2020</verification_date>
  <study_first_submitted>March 3, 2019</study_first_submitted>
  <study_first_submitted_qc>March 4, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">March 5, 2019</study_first_posted>
  <last_update_submitted>April 27, 2020</last_update_submitted>
  <last_update_submitted_qc>April 27, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">April 28, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Amani Hassan Abdel-Wahab</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>TAP block</keyword>
  <keyword>inguinal hernia</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dexamethasone</mesh_term>
    <mesh_term>Dexamethasone acetate</mesh_term>
    <mesh_term>Bupivacaine</mesh_term>
    <mesh_term>BB 1101</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

